ENTX logo

Entera Bio Ltd. (ENTX)

Profile

Full Name

Entera Bio Ltd.

Ticker

NASDAQ: ENTX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Israel

IPO

June 28, 2018

Indexes

Not included

Website

https://www.enterabio.com

Employees

18

Key Details

Price

$1.94(+2.34%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$181.00K(+100.00% YoY)

Annual EPS

-$0.25(+19.35% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.94
    ENTX price is $1.94

    30-Day Relative Volume

    1.00
    ENTX 30-day relative volume is 1.00

    Price Performance

    Price Today change

    +2.34%
    ENTX price is up +2.34% today

    Price YTD change

    -8.28%
    ENTX price is down -8.28% since January 1st

    Price 1-year change

    +17.84%
    ENTX price is up +17.84% year-on-year

    Price 3-year change

    +23.06%
    ENTX price is up +23.06% over the past 3 years

    Price Range

    Price All-time high

    $10.16
    ENTX price is currently -80.86% below its historical high of $10.16

    Price 3-year low

    $0.47
    ENTX price is currently +311.95% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $88.79M
    ENTX market capitalization is $88.79 million

    Market cap 3-year change

    +95.05%
    ENTX market capitalization is up +95.05% over the past 3 years

    Market cap All-time high

    $177.92M
    ENTX market capitalization is currently -50.10% below its historical high of $177.92 million

    Market cap sector rank

    40.8%
    ENTX market capitalization is higher than 40.8% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +25.71%
    ENTX shares outstanding is up +25.71% year-on-year

    Shares Outstanding 3-Year Change

    +58.5%
    ENTX shares outstanding is up +58.5% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.51
    ENTX beta is 0.51

    200-day SMA

    $2.01
    ENTX price is currently -3.15% below its 200-day simple moving average

    50-day SMA

    $1.95
    ENTX price is currently -0.06% below its 50-day simple moving average

    RSI

    46.93
    ENTX 14-day relative strength index is 46.93

    Volume

    1.00
    ENTX 30-day relative volume is 1.00

    ATR

    $0.10
    ENTX average true range is $0.10

    10-day Historical Volatility

    61.74%
    ENTX 10-day historical volatility is 61.74%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $181.00K
    ENTX annual revenue is $181.00 thousand

    Revenue Analysts estimate

    $42.00K
    ENTX annual revenue is currently +330.95% higher than the consensus analysts' forecast

    Revenue 1-year change

    +100%
    ENTX annual revenue is up +100% year-on-year

    Revenue Sector rank

    32.56%
    ENTX annual revenue is higher than 32.56% of companies in Healthcare sector

    EPS

    EPS

    -$0.25
    ENTX annual earnings per share is -$0.25

    EPS Analysts estimate

    -$0.32
    ENTX annual earnings per share is currently -21.88% lower than the consensus analysts' forecast

    EPS 1-year change

    +19.35%
    ENTX annual earnings per share is up +19.35% year-on-year

    EPS Sector rank

    69.88%
    ENTX annual earnings per share is higher than 69.88% of companies in Healthcare sector

    Profit

    Gross profit

    $9000.00
    ENTX annual gross profit is $9000.00

    Gross margin

    4.97%
    ENTX annual gross profit margin is 4.97%

    Operating profit

    -$9.59M
    ENTX annual operating income is -$9.59 million

    Operating margin

    -5295.58%
    ENTX annual operating profit margin is -5295.58%

    Net income

    -$9.54M
    ENTX annual net profit is -$9.54 million

    Net margin

    -5271.27%
    ENTX annual net profit margin is -5271.27%

    Expenses

    Total expenses

    $9.77M
    ENTX annual total expenses is $9.77 million

    Operating expenses

    $9.59M
    ENTX annual total operating expenses is $9.59 million

    Cost of goods sold

    $172.00K
    ENTX annual cost of goods sold is $172.00 thousand

    Selling, general & administrative expenses

    $5.09M
    ENTX annual SGA is $5.09 million

    Depreciation and amortization

    $46.00K
    ENTX annual depreciation & amortization is $46.00 thousand

    Interest expense

    $0.00
    ENTX annual interest expense is $0.00

    Income tax

    $14.00K
    ENTX annual income tax is $14.00 thousand

    EBIT & EBITDA

    EBIT

    -$9.59M
    ENTX annual earnings before interest & taxes is -$9.59 million

    EBITDA

    -$9.54M
    ENTX annual EBITDA is -$9.54 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $9.39M
    ENTX annual total assets is $9.39 million

    Non current assets

    $418.00K
    ENTX annual long term assets is $418.00 thousand

    Current assets

    $8.97M
    ENTX annual total current assets is $8.97 million

    Cash and cash equivalents

    $8.66M
    ENTX annual cash & cash equivalents is $8.66 million

    Accounts receivable

    $126.00K
    ENTX annual accounts receivable is $126.00 thousand

    Inventory

    $0.00
    ENTX annual inventory is $0.00

    Liabilities

    Total liabilities

    $1.31M
    ENTX annual total liabilities is $1.31 million

    Long term liabilities

    $134.00K
    ENTX annual total long term liabilities is $134.00 thousand

    Current liabilities

    $1.18M
    ENTX annual total current liabilities is $1.18 million

    Accounts payable

    $132.00K
    ENTX annual accounts payable is $132.00 thousand

    Debt

    Total debt

    $272.00K
    ENTX annual total debt is $272.00 thousand

    Total debt 1-year change

    -30.26%
    ENTX annual total debt is down -30.26% year-on-year

    Long term debt

    $102.00K
    ENTX annual long term debt is $102.00 thousand

    Short term debt

    $170.00K
    ENTX annual short term debt is $170.00 thousand

    Equity & Capital

    Shareholders equity

    $8.08M
    ENTX annual stockholders equity is $8.08 million

    Book value

    $8.08M
    ENTX annual book value is $8.08 million

    Retained earnings

    -$113.93M
    ENTX annual retained earnings is -$113.93 million

    Working capital

    $7.80M
    ENTX annual working capital is $7.80 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$6.82M
    ENTX annual cash flow from operations is -$6.82 million

    Cash from operations 1-year change

    +6.73%
    ENTX annual cash flow from operations is up +6.73% year-on-year

    Cash from investing

    -$3000.00
    ENTX annual cash flow from investing activities is -$3000.00

    Cash from investing 1-year change

    +82.35%
    ENTX annual cash flow from investing activities is up +82.35% year-on-year

    Cash from financing

    $4.48M
    ENTX annual cash flow from financing activities is $4.48 million

    Cash from financing 1-year change

    -25.84%
    ENTX annual cash flow from financing activities is down -25.84% year-on-year

    CAPEX

    CAPEX

    $3000.00
    ENTX annual capital expenditures is $3000.00

    CAPEX 1-year change

    -82.35%
    ENTX annual capital expenditures is down -82.35% year-on-year

    Free Cash Flow

    Free cash flow

    -$6.82M
    ENTX annual free cash flow is -$6.82 million

    Free cash flow 1-year change

    +6.91%
    ENTX annual free cash flow is up +6.91% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    4.97%
    ENTX annual gross profit margin is 4.97%

    Operating margin

    -5295.58%
    ENTX annual operating profit margin is -5295.58%

    Net margin

    -5271.27%
    ENTX annual net profit margin is -5271.27%

    ROA & ROE

    ROA

    -90.20%
    ENTX annual return on assets is -90.20%

    ROE

    -103.34%
    ENTX annual return on equity is -103.34%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ENTX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ENTX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    5.15
    ENTX price to book ratio is 5.15

    PB ratio Sector rank

    79.27%
    ENTX price to book ratio is higher than 79.27% of companies in Healthcare sector

    PS Ratio

    PS ratio

    534.87
    ENTX price to sales ratio is 534.87

    PS ratio Sector rank

    96.81%
    ENTX price to sales ratio is higher than 96.81% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $70.12M
    ENTX enterprise value is $70.12 million

    Enterprise value Sector rank

    44.1%
    ENTX enterprise value is higher than 44.1% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -6.64
    ENTX EV/EBITDA is -6.64

    EV/EBITDA Sector rank

    17.85%
    ENTX EV/EBITDA is higher than 17.85% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    7.63
    ENTX annual current ratio is 7.63

    Quick ratio

    7.63
    ENTX annual quick ratio is 7.63

    Leverage

    Debt to equity

    0.03
    ENTX annual debt to equity ratio is 0.03

    Interest coverage ratio

    -
    ENTX annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    ENTX piotroski f-score value is unknown

    Altman Z-Score

    21.33
    ENTX altman z-score is 21.33

    Analyst ratings

    Recent major analysts updates

    Mar 18, 25 HC Wainwright & Co.
    Buy
    Nov 11, 24 HC Wainwright & Co.
    Buy
    Oct 7, 24 HC Wainwright & Co.
    Buy
    Sep 27, 24 HC Wainwright & Co.
    Buy
    Aug 12, 24 HC Wainwright & Co.
    Buy
    Jun 5, 24 HC Wainwright & Co.
    Buy
    May 14, 24 HC Wainwright & Co.
    Buy
    May 13, 24 HC Wainwright & Co.
    Buy
    Apr 2, 24 HC Wainwright & Co.
    Buy
    Dec 11, 23 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with ENTX included

    Growing Shares Outstanding
    Stocks below SMA 200
    Most recommended stocks
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    High Altman Z score stocks
    • What is the ticker symbol for Entera Bio Ltd.?
    • Does Entera Bio Ltd. pay dividends?
    • What sector is Entera Bio Ltd. in?
    • What industry is Entera Bio Ltd. in?
    • What country is Entera Bio Ltd. based in?
    • When did Entera Bio Ltd. go public?
    • Is Entera Bio Ltd. in the S&P 500?
    • Is Entera Bio Ltd. in the NASDAQ 100?
    • Is Entera Bio Ltd. in the Dow Jones?
    • When was Entera Bio Ltd.'s last earnings report?
    • When does Entera Bio Ltd. report earnings?

    What is the ticker symbol for Entera Bio Ltd.?

    The ticker symbol for Entera Bio Ltd. is NASDAQ:ENTX

    Does Entera Bio Ltd. pay dividends?

    No, Entera Bio Ltd. does not pay dividends

    What sector is Entera Bio Ltd. in?

    Entera Bio Ltd. is in the Healthcare sector

    What industry is Entera Bio Ltd. in?

    Entera Bio Ltd. is in the Biotechnology industry

    What country is Entera Bio Ltd. based in?

    Entera Bio Ltd. is headquartered in Israel

    When did Entera Bio Ltd. go public?

    Entera Bio Ltd.'s initial public offering (IPO) was on June 28, 2018

    Is Entera Bio Ltd. in the S&P 500?

    No, Entera Bio Ltd. is not included in the S&P 500 index

    Is Entera Bio Ltd. in the NASDAQ 100?

    No, Entera Bio Ltd. is not included in the NASDAQ 100 index

    Is Entera Bio Ltd. in the Dow Jones?

    No, Entera Bio Ltd. is not included in the Dow Jones index

    When was Entera Bio Ltd.'s last earnings report?

    Entera Bio Ltd.'s most recent earnings report was on November 9, 2022

    When does Entera Bio Ltd. report earnings?

    The date for Entera Bio Ltd.'s next earnings report has not been announced yet
    On this page